AMY GLASCO: Open Payments
NPI 1689241309 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 26 payments from 11 companies in 2025. Trend: 2023 $407 · 2024 $248 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $191 |
| ABIOMED | 1 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $101 |
| Amgen Inc. | 4 | $65 |
| Alnylam Pharmaceuticals Inc. | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| SCPHARMACEUTICALS INC. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| CVRx, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: JARDIANCE, Kerendia, REPATHA, AMVUTTRA, FUROSCIX, FARXIGA, VERQUVO, Barostim Neo System.
Industry payments across IL — which companies pay providers there.
